Fluorinated Cationic Lipids for Stable Intracellular RNA Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current nucleic acid delivery systems face challenges such as susceptibility to nuclease digestion in plasma and limited intracellular access, necessitating improved cationic lipids and lipid nanoparticles for effective protection and delivery.
Innovation Solution
Development of novel fluorinated cationic lipids combined with other lipid components to form lipid nanoparticles that enhance nucleic acid protection, stability, and intracellular delivery, while maintaining tolerability and therapeutic index.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If free RNA is used for delivery, then simplicity of administration is maintained, but susceptibility to nuclease digestion in plasma increases
Solution Approach 1:
Lipid nanoparticles serve as an intermediary carrier system that protects RNA from plasma nucleases while enabling delivery. The lipid nanoparticle composition includes ionizable cationic lipids, neutral lipids, and cholesterol that form protective structures around the RNA payload, shielding it from enzymatic degradation in the plasma environment.
2Device complexity
If free RNA is used for delivery, then complexity of delivery system is minimized, but ability to gain access to intracellular compartment is limited
Solution Approach 1:
The ionizable cationic lipids undergo pH-dependent parameter changes that enable intracellular delivery. At endosomal pH, the lipids become protonated and adopt non-bilayer structures that disrupt endosomal membranes, facilitating RNA release into the cytoplasm. This pH-triggered structural transition enables the delivery system to overcome cellular barriers.
3Reliability
If conventional cationic lipids are used in lipid nanoparticles, then protection from degradation and clearance in serum is achieved, but toxicity increases
Solution Approach 1:
The cationic lipids are designed with localized functional properties: the ionizable amine group provides charge for RNA complexation and endosomal disruption, while the fluorinated alkyl chains provide hydrophobicity and membrane interaction. This spatial separation of functions within the lipid structure enables effective delivery while reducing off-target toxicity through optimized local interactions.
4Reliability
If optimized lipid nanoparticle composition is used, then intracellular delivery efficiency is improved, but device complexity increases
Solution Approach 1:
The lipid nanoparticle employs a composite material strategy combining four key components: ionizable cationic lipids (for complexation and endosomal escape), neutral lipids (for structural stability), cholesterol (for membrane interaction and stability), and PEGylated lipids (for steric stabilization). Each component contributes specific properties that collectively enable efficient intracellular delivery while maintaining a manageable formulation complexity.
Data Source
AI summary
Compounds are provided having the following structure: or a pharmaceutically acceptable salt, tautomer or stereoisomer thereof, wherein R2a, R2b, R3a, R3b, R7, R8, R9, L1, L2, G1, G2, G3, b, and c are as defined herein. Use of the compounds as a component of lipid nanoparticle formulations for delivery of a therapeutic agent, compositions comprising the compounds and methods for their use and preparation are also provided.